Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 전대원 | - |
dc.date.accessioned | 2018-03-17T05:08:03Z | - |
dc.date.available | 2018-03-17T05:08:03Z | - |
dc.date.issued | 2014-04 | - |
dc.identifier.citation | Clinical and Molecular Hepatology, 2014, 20(1). P.18-27 | en_US |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.issn | 2287-285X | - |
dc.identifier.uri | https://www.e-cmh.org/journal/view.php?doi=10.3350/cmh.2014.20.1.18 | - |
dc.description.abstract | Background/Aims: This retrospective study assessed the clinical outcome of a transjugular intrahepaticportosystemic shunt (TIPS) procedure for managing portal hypertension in Koreans with liver cirrhosis. Methods: Between January 2003 and July 2013, 230 patients received a TIPS in 13 university-based hospitals. Results: Of the 229 (99.6%) patients who successfully underwent TIPS placement, 142 received a TIPS for varicealbleeding, 84 for refractory ascites, and 3 for other indications. The follow-up period was 24.9±30.2 months (mean±SD),74.7% of the stents were covered, and the primary patency rate at the 1-year follow-up was 78.7%. Hemorrhageoccurred in 30 (21.1%) patients during follow-up; of these, 28 (93.3%) cases of rebleeding were associated with stentdysfunction. Fifty-four (23.6%) patients developed new hepatic encephalopathy, and most of these patients weresuccessfully managed conservatively. The cumulative survival rates at 1, 6, 12, and 24 months were 87.5%, 75.0%,66.8%, and 57.5%, respectively. A high Model for End-Stage Liver Disease (MELD) score was significantly associatedwith the risk of death within the first month after receiving a TIPS (P=0.018). Old age (P<0.001), indication for a TIPS(ascites vs. bleeding, P=0.005), low serum albumin (P<0.001), and high MELD score (P=0.006) were associated withoverall mortality. Conclusions: A high MELD score was found to be significantly associated with early and overall mortality rate in TIPSpatients. Determining the appropriate indication is warranted to improve survival in these patients. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Korean Association for the Study of the Liver | en_US |
dc.subject | Liver cirrhosis | en_US |
dc.subject | Transjugular intrahepatic portosystemic shunt | en_US |
dc.subject | Portal hypertension | en_US |
dc.title | Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data | en_US |
dc.type | Article | en_US |
dc.relation.no | 1 | - |
dc.relation.volume | 20 | - |
dc.identifier.doi | 10.3350/cmh.2014.20.1.18 | - |
dc.relation.page | 18-27 | - |
dc.relation.journal | Clinical and Molecular Hepatology | - |
dc.contributor.googleauthor | Kim, H.K. | - |
dc.contributor.googleauthor | Kim, Y.J. | - |
dc.contributor.googleauthor | Chung, W.J. | - |
dc.contributor.googleauthor | Kim, S.S. | - |
dc.contributor.googleauthor | Shim, J.J. | - |
dc.contributor.googleauthor | Choi, M.S. | - |
dc.contributor.googleauthor | Kim, D.Y. | - |
dc.contributor.googleauthor | Jun, D.W. | - |
dc.contributor.googleauthor | Um, S.H. | - |
dc.contributor.googleauthor | Park, S.J. | - |
dc.relation.code | 2014001273 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | noshin | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.